Cytomegalovirus Colitis Following Azacitidine Therapy
The present report describes the first recognized case of cytomegalovirus (CMV) colitis following azacitidine therapy. A 66-year-old woman with myelodysplastic syndrome developed CMV colitis, which responded to treatment with ganciclovir. Currently, patients receiving azacitidine do not undergo CMV...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Sprog: | English |
| Udgivet: |
Hindawi Limited
2011-01-01
|
| Serier: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online adgang: | http://dx.doi.org/10.1155/2011/616725 |
| Summary: | The present report describes the first recognized case of cytomegalovirus (CMV) colitis following azacitidine therapy. A 66-year-old woman with myelodysplastic syndrome developed CMV colitis, which responded to treatment with ganciclovir. Currently, patients receiving azacitidine do not undergo CMV testing, or receive prophylaxis or CMV-free blood products; however, this policy needs to be revised. |
|---|---|
| ISSN: | 1712-9532 |